Table 6.
aba-ada exposure |
ubu-udu exposure |
|||||||
---|---|---|---|---|---|---|---|---|
factor |
b
|
SE
|
Z
|
P
|
b
|
SE
|
z
|
p
|
(Intercept) | 0.1 | 0.23 | 0.43 | .66 | −0.04 | 0.15 | −0.25 | .8 |
Continuum | −2.24 | 0.20 | −11.1 | <.001 | −2.34 | 0.17 | −13.68 | <.001 |
POA | 0.43 | 0.17 | 2.54 | <.01 | 0.13 | 0.15 | 0.87 | .38 |
TrialType | 0.93 | 0.50 | 1.85 | .065 | −0.84 | 0.34 | −2.52 | <.05 |
Continuum:POA | 0.02 | 0.19 | 0.09 | .93 | 0.22 | 0.18 | 1.17 | 0.24 |
Continuum:TrialType | −0.66 | 0.34 | −1.92 | .055 | 0.97 | 0.29 | 3.39 | <.001 |
POA:TrialType | 1.39 | 0.3 | 4.67 | <.001 | 0.7 | 0.31 | 2.24 | <.05 |
Continuum:POA:TrialType | −0.6 | 0.43 | −1.39 | .17 | −0.66 | 0.32 | −2.02 | <.05 |